1.A clinical and immunohistochemical study of gastrointestinal stromal tumours.
The Malaysian journal of pathology 2005;27(1):9-16
AIM: To study the clinical features, histology and immunohistochemical properties of gastrointestinal stromal tumours (GISTs); and establish any parameters that can help prognosticate the malignant potential. METHODS: Twenty-six patients with GISTs who were seen in Sultanah Aminah Hospital Johor, Malaysia from 1999 to 2003 were selected for study. Patient, clinical characteristics and outcome based on surgical records were analysed. Tumour variables (tumour size, cellularity, mitotic count, necrosis and haemorrhage) were compared between very low to low risk groups and intermediate to high risk groups. The immunohistochemical properties of GISTs were also studied. RESULTS: Patients with GISTs presented mainly with pain, palpable mass or gastrointestinal tract bleeding. The tumours were seen in stomach (50%) followed by small intestine (38.5%) and rectum (11.5%). In the period of study, six patients had metastasis, mainly in the liver or peritoneum. Immunoreactivity for CD117, CD34, vimentin, S100, neuron specific enolase, alpha-smooth-muscle-actin and desmin were observed in 100%, 76.9%, 61.5%, 46.1%, 80.8%, 11.5% and 0% of tumours respectively. The behaviour of GISTs was largely dependent on tumour size and number of mitosis. Necrosis and haemorrhage were seen in tumours with high risk potential.
Gastrointestinal
;
Clinical
;
Risk
;
Hemorrhage
;
SIZES
2.Pattern of hMLH1, hMSH2 and hMSH6 expression and clinical characteristics in a sample of Malaysian colorectal carcinoma cases
Joon-Joon Khoo ; Andrew Gunn ; Suat-Cheng Peh
The Malaysian Journal of Pathology 2013;35(1):45-57
Malignant transformation from normal colonic mucosa to carcinomas may be accelerated by
genetic loss or inactivation of genes of the DNA mismatch repair system. The aim of the study
was to determine the local incidence and pattern of immunohistochemical expression of mismatch
repair proteins namely: hMLH1, hMSH2 and hMSH6 in a series of colorectal carcinomas (CRCs)
and correlate this to their clinical and pathological features. Forty-three out of 298 cases of CRCs
(14.4%) showed abnormal staining pattern for mismatch repair proteins with a majority (65.1%)
showing single hMLH1 loss. Tumours with mismatch repair defect (MMR-d) were frequently found
at the right side of colon (p<0.001), poorly differentiated carcinomas (p<0.001), produced more
mucin (p=0.007), exophytic growth (p=0.007) and were bigger (p=0.002) than tumours with no
mismatch repair defect. Immunohistochemical stains for mismatch repair proteins could be done in
local laboratories on these selected cases before referring for the expensive molecular test.